Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

A Gravimetric Approach to Sample Preparation at Pfizer

By Drug Discovery Trends Editor | February 6, 2014

Quantos QX7 from Mettler Toledo: A pioneering fully automated gravimetric sample preparation workstation.Awareness of the benefits of gravimetric sample preparation has increased significantly over the past couple of years. Recognition of this state-of-the-art technology by industry organizations such as the United States Pharmacopeia (USP) has supported this trend. A recent revision to USP chapter 1251 “Weighing on an Analytical Balance”, which became official on Dec 1, 2013, included a detailed description of the steps involved in gravimetric dosing for sample and standard preparation.

Pfizer’s Analytical Research and Development Group (AR&D) in Groton, Conn., have embraced this new approach to sample preparation using a pioneering fully automated gravimetric sample preparation workstation. Detailed studies have been carried out which compare the differences between preparing samples and standards using a conventional manual volumetric process and the new automated gravimetric method.

“Sample preparation is an analytical workflow focus area. We are delighted to have worked with Mettler-Toledo in the development and preliminary evaluation of the Quantos QX series.  A targeted automated (gravimetric) sample preparation approach with the QX has demonstrated improved precision, reduced sample and solvent consumption and less analyst time as compared to manual approaches,” says Gang Xue, associate research fellow, Pfizer ARD.

In this article, data is presented from a reproducibility/precision study performed by the Analytical Group, using the non-proprietary material caffeine. In this experiment sample preparation is performed manually with volumetric flasks and compared with a new fully automated method, where samples are prepared on a gravimetric sample preparation workstation (Quantos QX7 from Mettler Toledo). The QX7 workstation incorporates a six-place microbalance for weighing of the solids and solvents with automated interchange of up to 10 solid dosing heads and five solvent dosing heads.

Enhanced reproducibility and precision
This study investigated the reproducibility and precision of manual sample preparation compared to an automated gravimetric method. For the manual volumetric method, six replicate solutions were prepared by weighing 20 mg of caffeine on an analytical balance and making it up to 50 mL in a volumetric flask using a 30:70 methanol/water mixture. This procedure took a total of 50 min. Dissolving/mixing the samples on a shaker took 15 min of this time, so the manual labor time is 35 min full-time equivalent (FTE)—five minutes per sample for each weighing and dilution plus five minutes for the diluent prep. The relative standard deviation of these samples was 1.67%. Table 1 shows the manual volumetric data.

 

Sample Set Name:

MW Manual Repeatability

Sample Set Id:

18622

 

 

Result Set Id:

18740

 

 

 

 

 

 

 

 

 

Sample Name

Result ID

Name

Area (µV*sec)

Calc. Conc. (mg/mL)

1

M1

18744

Caffeine

5568747.28

0.413

2

M2

18745

Caffeine

5694384.72

0.423

3

M3

18746

Caffeine

5646098.85

0.419

4

M4

18747

Caffeine

5450694.28

0.405

5

M5

18748

Caffeine

5501403.13

0.408

6

M6

18749

Caffeine

5632460.66

0.418

Mean

 

 

 

 

0.41

%RSD

 

 

 

 

1.67

Table 1: Manual sample preparation using a volumetric flask – reproducibility and precision

 

Table 2 shows the equivalent data from the automated gravimetric method. Six replicate solutions were prepared by weighing 5 mg of caffeine and adding 12.5 g of the same diluent (30:70 methanol/water) directly into a vial. This procedure took a total of 30 min, consisting of 10 min preparation time—such as filling and installing powder and liquid dosing heads and setting up the sequence—with an additional 20 min running time. The RSD of these samples was 0.49%.

 

Sample Set Name:

MW Automated Repeatability

Sample Set Id:

17729

 

 

Result Set Id:

17808

 

 

 

 

 

 

 

 

 

Sample Name

Result Id

Name

Area (µV*sec)

Calc. Conc. (mg/mL)

1

A1

17812

Caffeine

5278355.59

0.377

2

A2

17813

Caffeine

5264847.66

0.376

3

A3

17814

Caffeine

5297039.30

0.378

4

A4

17815

Caffeine

5265959.19

0.376

5

A5

17816

Caffeine

5297020.61

0.378

6

A6

17817

Caffeine

5224532.00

0.373

Mean

 

 

 

 

0.38

%RSD

 

 

 

 

0.49

Table 2: Automated gravimetric sample preparation – reproducibility and precision

 

 


 

Manual Prep:

Automated Prep:

Difference:

Amount of substance

20 mg solid +
50 mL diluent

5 mg solid +
12.5 g diluent

Save 75% substance

Time

50 mins (total)

35 mins (FTE)

30 mins (total)

10 mins (FTE)

Save 70% labour time

Precision

%RSD = 1.67

%RSD = 0.49

Improve precision x 3

Table 3: Comparison between manual and automated sample preparation

 

This study highlights three key advantages of automated gravimetric sample preparation: 75% less substance and solvent are used to prepare the sample solutions; 70% of labor time is saved in the sample preparation steps; and, most importantly, the precision is improved by a factor of more than three.

Practical advantages of automated gravimetric sample preparation
The reproducibility of the samples prepared is significantly improved, which will have a knock-on effect in the quality of the analytical results generated, which in turn will lead to a reduction in out-of-specification results caused by weighing and dilution errors. The reduced labor time and amount of substance and solvent saved also has the potential to have a dramatic impact on laboratory efficiency and running costs for a typical analytical laboratory.

Revised version of the article first published in q&more 01/13. With friendly permission of Succidia AG


Filed Under: Drug Discovery

 

Related Articles Read More >

Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
First clinical study results of Dupixent for atopic dermatitis in patients with darker skin tones 
Labcorp widens precision oncology toolkit, aims to speed drug-trial enrollment
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE